SciencePhoto: RocheRoche Advances KRAS G12C Cancer Research with New Approach
Roche is pioneering research on KRAS G12C, a challenging cancer target, by adopting innovative scientific strategies. This fresh approach marks a significant shift from traditional methods, turning what was once science fiction into scientific reality in cancer treatment development. Scientists are exploring new angles to effectively target KRAS mutations, aiming to improve outcomes for cancer patients.
Roche·




